RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $521
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice TargetHot
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $496 to $521.
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $496 to $521.